Top Biotechnology & Medical Research stocks in Switzerland
Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
LONNLonza AG | CH₣37.91bn | 120.05 | 0.74% |
BANBBACHEM HOLDING AG | CH₣5.84bn | 51.09 | 1.03% |
BIONBB Biotech AG | CH₣2.04bn | 8.73 | 5.38% |
KURNKuros Biosciences AG | CH₣730.42m | n/a | n/a |
BSLNBasilea Pharmaceutica AG Allschwil | CH₣550.30m | n/a | n/a |
IDIAIdorsia | CH₣299.83m | n/a | n/a |
XLSXlife Sciences AG | CH₣172.25m | 14.39 | n/a |
MOLNMolecular Partners AG | CH₣155.68m | n/a | n/a |
RLFRELIEF THERAPEUTICS Holding SA | CH₣29.47m | n/a | n/a |
ADXNAddex Therapeutics | CH₣7.51m | n/a | n/a |
EVEEvolva Holding | CH₣6.20m | n/a | n/a |
OBSNObseva SA | CH₣0.14m | 0.04 | n/a |